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In the present study, we assessed the treatment eﬀects of PBDE-209 administration on the immune function in rats during
pregnancy and lactation. We harvested the blood and organs for ﬂow cytometry, viability assay, enzyme-linked immunosorbent
assay, and histological evaluation. The results of this study were the PBDE-209 exposure during pregnancy and lactation impairs
immune function in rats. The results may contribute to understanding the mechanism of PBDE-209 in immune function.
1.Introduction
Polybrominated diphenyl ethers (PBDEs) are a group of bro-
mide-containing compounds that has been wildly applied to
many dairy products as ﬂame retardants for several decades.
The PBDEs have been proven to be life saving by allowing
longer escape time and reduced overall damage during ﬁre
[1]. But there is really no evidence to support this claim that
PBDEs have been used in house wiring, electrical appliances,
TV, computers and mobile phones, building materials, and
numerous plastic products [2–4]. While there are potentially
209 PBDE congeners, there are only 3 major commercial
mixtures which contain a limited number, present in penta-,
octa-, or decabrominated forms. PBDE-209 is not lipophi-
lic—it accumulates in the blood and liver, bound to proteins.
Many of the lower brominated congeners are lipophilic and
can be accumulated in fatty tissue and pass into food chain.
High concentration of PBDEs has been detected in tropical
ﬁsh or lipid-rich oils. Therefore, PBDEs have become a con-
stant environmental pollutant [5].
In recent years, increasing concerns have focused on the
potential adverse eﬀects of PBDEs in humans. Numerous
studies have shown that PBDEs exert a wide range of tox-
ic eﬀects in many organ systems, such as disruption of thy-
roid function and neurotoxicity during development [6–8].
Further, mice exposed to isomer PBDE 47 suppress lympho-
cytes proliferation and antibodies production [9]. These
ﬁndings suggest that exposure to PBDE may modulate the
functions and structure of immune system. Among PBDEs,
the polybrominated diphenyl ether-209 (PBDE-209, a deca-
BDE) is a highly brominated PBDE with 10 bromine atoms
and receives a lot of attentions. The PBDE-209 can be re-
leased into the environment by a variety of processes, such as
emissionsduringmanufactureofdecaBDE-containingprod-
ucts or/and from the products themselves. The PBDE-209
has showed toxic eﬀects during development of central nerve
system in neonatal rats, especially in large doses [8]. Even
though there have been multiple human studies on PBDEs,
there is limited information regarding the adverse eﬀects of
PBDE-209 in the immune functions in animals and humans
during pregnancy and lactation. Based on our previous
ﬁndings that there is a decrease in immune function after the
PBDE-209 exposure in vivo in pups [10], the present study
is designed to further characterize the immune function im-
pairment following PBDE-209 exposure in vivo during preg-
nancy and lactation in dams. Changes in immune function
after PBDE-209 exposure in vivo is evaluated by measuring
serum cytokines and immunoglobulin, as well as other spec-
iﬁc biological markers and lymphocyte diﬀerentiation, and
correlated with histopathological ﬁndings. We demonstrated2 Mediators of Inﬂammation
a profound toxicity in immune system in rats during preg-
nancy and lactation following PBDE-209 exposure in vivo.
Our ﬁndings indicate that exposure to PBDE-209 in vivo
produces immunosuppressive eﬀects in rats during pregnan-
cy and lactation.
2.MaterialsandMethods
2.1. Animals. Female Sprague-Dawley rats, age of postnatal
day (PND) 21, were purchased from the Experimental Ani-
mal Centre of Southern Medical University, China, then ran-
domlydividedintocontrolandexperimentalgroups.Nosig-
niﬁcantly diﬀerence was observed between control and ex-
perimental group for their initial body weight. Rats were
housed with 12-hour light/dark cycle in the pathogen-free
unit and were provided with animal food and water. All
behavioural studies were conducted between 2:00 PM to
4:00 PM. The rats were accustomed in SPF standards animal
laboratory, and they were mated at 4:00 PM–7:00 AM. The
animal care and experimental practice at Southern Medical
University are regularly inspected by the University Animal
Care and Use Committee and by governmental agencies to
ensure compliance with international regulations and guide-
lines.
2.2.Chemicals. PBDE-209wasobtainedfromSigma-Aldrich
Co. Ltd., USA. The purity of PBDE-209 was 98%. Mouse
anti-rat FITC conjugated, anti-CD3 PE conjugated, anti-
CD4 PE conjugated, anti-CD8 FITC conjugated, anti-CD161
and mouse PE-Cy5-labeled IgG1, FITC-labelled IgG1, and
PE-labelled IgG1 were purchased from Serotech Co. Ltd.,
Netherlands. Primary mouse anti-rat IgG, goat anti-mouse
immunoglobulins conjugated to horseradish peroxidase sec-
ondary antibodies, DAB Reagent set (KPL), serum IgM, IgG,
interleukin-4 and interferon-γ ELISA kit were purchased
from Jingmei Biotechnology Co. Ltd., China. Pentobarbital
was purchased from Sigma-Aldrich, St. Louis, MO.
2.3. Experimental Groups. The rats were randomly divided
intotwogroups:experimentalandcontrol.Theexperimental
group(n = 20)wereintragastricallyadministeredPBDE-209
in 2mL arachis oil (0.3g/kg/day) from postnatal day 21 until
theiroﬀsprings3weeks.TheanimalsdosedfromPND21un-
tiltheiroﬀspringwereweanedweremorethan14weeks.The
control group was given 2mL puriﬁed arachis oil.
2.4. Experimental Protocol. After PBDE-209 administration,
rats were anesthetised with intraperitoneal injection of pen-
tobarbital (20mg/kg) and scariﬁed. The venous blood was
collected in a 10mL sterile tube from each rat without add-
inganticoagulantandstoredat −20◦C.Liver,spleen,thymus,
and ovaries were dissected and weighed immediately after
dissection. The dissected organs/tissues were ﬁxed in 10%
formalin for further histological processing. Prior to assay,
blood samples were thawed out to room temperature by gen-
tle swirling and inversion. All sera separated from blood at
3000P/m for 15 minutes were stored at −20◦C for further
assay. All sera were assayed on the same day to avoid inter-
assay variation.
2.5. Flow Cytometry. The lymphocytes were extracted as
previously described [11]. Brieﬂy, the thymus tissues were
dissociated into a single cell suspension by passing through a
100/47 gauge nylon mesh (Tetko, Depew, NY). The lympho-
cytes are collected and cultured in 6-well plates with approx-
imately 1 × 106 cells/well. The cells were then centrifuged for
5min at 1000rpm and incubated with 10μL mouse anti-rat
monoclonal antibodies in 300μL PBS as follows: FITC-con-
jugated monoclonal antibodies (Mab) against CD3, PE-con-
jugated anti-CD4, PE-conjugated anti-CD8. The cells were
allowed to incubate without light source at 37◦C for 20min.
After another 5min centrifugation at 1000rpm, the cells
were resuspended with PBS and 300μLH B S Sb u ﬀer solution
and the lymphocytes were analysed by ﬂow cytometry (exci-
tation at 488nm and emission at 525nm, Becton Dickinson,
USA) to detect T lymphocyte surface antigens.
2.6. Viability Assay by CCK-8. Previous experiment has
showed that CCK-8 method was sensitive to detect lympho-
cyte cell viability at 5μg/mL phytohemagglutinin or lipopol-
ysaccharide buﬀer with approximately 5 × 106 To rBl y m -
phocyte cells/mL. In present experiment, the aliquots were
distributed into a 96-well plate and incubated for 72h at
37◦C. After the incubation period, CCK-8 solution was add-
ed to the culture medium and the cells were further incub-
ated for 6h. With adding DMSO, the absorbance at a wave-
lengthof450nmwithareferencedwavelengthof630nmwas
measured.
2.7. Enzyme-Linked Immunosorbent Assay. The concentra-
tions of interferon-γ, IgM, and interleukin-4 in sera har-
vested from PBDE-209-treated rats were measured by enzy-
me-linked immunosorbent assay in accordance with prev-
iously described protocol. Brieﬂy, 96-well microtiter plates
(NUNC-Immunok Plate) were coated with immunoaﬃnity-
puriﬁed polyclonal antibodies against the respective cyto-
kines overnight at 4◦C. After blocking the nonspeciﬁc bind-
ing with 1% albumin for 1h, cytokine standards and experi-
mental samples were loaded together and incubated for
90min at 37◦C. Biotin-conjugated antibody was added, fol-
lowed by an additional incubation for 1h at 37◦C. Finally,
100μL of avidin-conjugated horseradish peroxidase (1:100
dilution; Jingmei, China) was added into each well. After
30min incubation, the plates were washed and the colour re-
agent TMB (100μL/well) was added and allowed to react for
15min,thenreactionwasstoppedby1MH2SO4 andtheOD
was measured at 450nm. The cytokine concentration was
expressed as pgmL−1.
2.8.HistologicalMethodsandEvaluation. For histological ex-
amination of organs, rats exposed to PBDE-209 were sac-
riﬁced on oﬀspring postnatal day 21, and the liver, spleen,
thymus, and ovaries were removed and placed in buﬀered
formalin for a minimum of 24h. After 10% formalin ﬁx-
ation, organs sampled for histology were dehydrated andMediators of Inﬂammation 3
Table 1: Weight of body and organs (g).
Detection index Control group Experimental group
rat weight 284.00 ±23.98 251.24 ±32.73∗
thymic weight 0.21 ±0.03 0.20 ±0.03
thymus index number 0.75 ±0.10 0.80 ±0.11
spleen weight 0.67 ±0.04 0.75 ±0.03∗∗
spleen index number 2.37 ±0.19 3.00 ±0.30∗∗

































































































Figure 1: We measured the percentage of T lymphocytes in
blood of exposed Sprague-Dawley (SD) rats using ﬂow cytometric
analysis. Values are expressed as mean ± standard deviation, and
are representative of two separate experiments with twenty rats per
group in each experiment.
∗P < 0.05 compared to control group.
paraﬃnized and embedded according to standard sampling
and trimming procedures. 3μm sections were prepared and
stained with haematoxylin and eosin within an automated
machine. An observer who had no knowledge of the research
intent and was blind to the origin of the sample performed
the tissue analysis. The observer scored the severity of organs
in the tissue sections.We made all evaluations on ﬁve ﬁelds
per section and ﬁve sections per organ.
2.9. Statistical Analysis. A l ld a t aw e r ee x p r e s s e da sm e a n±
standard deviation (SD). Statistical analyses were performed
using Statistical Package for the Social Sciences (SPSS) Ver-
sion 13.0 for Windows. Comparisons of serum interferon-γ
and interleukin-4, body and organ weights, T lympho-
cyte subset markers, lymphocyte viability, serum IgM, ser-
u mI g G ,a n dN Kc e l ls u r f a c em a r k e r sb e t w e e nc o n t r o la n d
experimental groups were carried out using one-way analysis
of variance (ANOVA) followed by a post hoc test (Bonfer-
roni’s method). We analyzed histological scored using the
Kruskal-Wallis test followed by the Mann-Whitney U-test.
A P value of less than 0.05 was considered to be statistically
signiﬁcant.
3. Results
3.1. Eﬀects of PBDE-209 Exposure on Body and Organ Weight.
The body weight of experimental group was signiﬁcantly
lighter than control group (t = 2.55, P<0.05) (Table 1).
Spleen and spleen index were heavier in experimental rats
in comparison to control group (t = −4.90, −5.71, resp., P<
0.01). The thymus weight and thymus index of experimental
rats were not signiﬁcantly diﬀerent from control group (t =
1.05, −0.98, resp., P>0.05).
3.2. Eﬀects of PBDE-209 Exposure on Surface Markers of T
Cells or NK Cells. Using ﬂow cytometric analysis technique,
the percentage of T lymphocytes in blood was measured in
Sprague-Dawley rats exposed to PBDE-209 (Figure 1). The
percentage of lymphocytes stained with CD3+,C D 4 +,
CD3+CD8+,C D 3 +CD4+, and the ratio CD4+/CD8+ were
decreased signiﬁcantly in experimental group (t = 3.56, 5.09,
3.12, 4.0, and 3.77, resp.; P<0.05). The percentage of
CD4−CD8− lymphocytes was signiﬁcantly increased (t =
−2.15, P<0.05) in experimental group. No signiﬁcant cha-
nges were observed in the percentage of CD8+,C D 4 +CD8+,
CD4−CD8+, and CD4+CD8− lymphocytes after exposure to
PBDE-209 (t = 0.85, 0.98, −0.91, −0.08, resp., P>0.05).
There is signiﬁcant decrease in surface CD161 expression on
NK cells in experimental group when compared to control
group (t = 9.27, P<0.05) (Table 3).
3.3. Eﬀects of PBDE-209 Exposure on Lymphocyte Viability.
The CCK-8 method was applied in the present study to
measure the viability of T and B lymphocytes from blood
sample taken from PBDE-209-exposed Sprague-Dawley rats.
The OD decreased in experimental group in applying with
phytohemagglutininstimulus,andincreasedinexperimental
group without phytohemagglutinin stimulus. OD decreased
in experimental group in applying with lipopolysaccharide
stimulus, decreased in experimental group without lipopol-
ysaccharide stimulus. Stimulus index is stimulated index =
OD value in stimulate hole/OD value in controlled hole. T
lymphocyte stimulus index decreased in the experimental
groupinapplyingwithphytohemagglutininstimulus,Blym-
phocyte stimulus index increased in the experimental group
in applying with lipopolysaccharide stimulus (Table 2).
3.4. Eﬀects of PBDE-209 Exposure on Serum IgM, IgG,
Interferon-γ, and Interleukin-4. Serum level of IgM, IgG, in-
terferon-γ, and interleukin-4 was measured by enzyme-
linked immunosorbent assay (ELISA). The serum levels of
IgM of experimental rats were signiﬁcantly lower than those
in the control rats (t = 2.54, P<0.05) (Table 3). Serum level
ofIgGwasalsosigniﬁcantlydecreasedinexperimentalgroup
(t = 2.60, P<0.05) (Table 3). No signiﬁcant diﬀerences were
detected in serum level of interleukin-4 or interferon-γ be-
tween experimental group and control group (t = 0.29, 1.29,
resp., P>0.05) (Table 3).
3.5.HistopathologicalChangesafterPBDE-209Exposure. The
thymus, spleen, liver, and ovaries were sectioned, stained
with H&E, and the slides were evaluated by pathologist. The
experimental group showed an obvious change in morphol-
ogy following PBDE-209 exposure (Figures 2(a)–2(p)). His-












tissues (arrow); (b) experimental group (100X)connective tissues (arrow); (c) control group (200X), corticomedullary (green arrow) thymic
corpuscles(blackarrow);(d)controlgroup(100X)Spleen:(e)experimentalgroup(200X);(f)experimentalgroup(400X);(g)controlgroup
(200X), ﬁbrous connective tissue(arrow); (h) control group (100X). Ovaries: (i) experimental group (200X), follicular atresia (arrow); (j)
experimental group (100X); (k) control group (200X), follicular (arrow); (l) control group (100X) Liver: (m) experimental group (200X),
eosinophilic bodies (blue arrow), ballooned change (green arrow); (n) central vein (arrow) experimental group (100X); (o) control group
(200X), eosinophil (arrow); (p) control group (100X).6 Mediators of Inﬂammation
Table 2: T and B lymphocytes OD value.
Group OD with PHA (LPS) stimulus OD with no PHA (LPS) stimulus OD stimulus index
Control group 0.87 ±0.11 0.26 ±0.09 3.55 ±0.97
(1.29 ±0.48) (1.03 ±0.48) (1.21 ±0.04)
Experimental group 0.70 ±0.17∗ 0.42 ±0.10∗∗ 1.69 ±0.20∗∗
(0.57 ±0.11∗∗)( 0 .31 ±0.12∗∗)( 1 .80 ±0.33∗)
Mean ± standard deviation, ∗P < 0.05, ∗∗P < 0.01.
Table 3: IgM, IgG, IFN-γ, and IL-4 levels in serum as measured by enzyme-linked immunosorbent assay and percentage of NK cells with
CD161 surface markers.
Group IgM (μg/mL) IgG (μg/mL) IFN-γ (pg/mL) IL-4 (pg/mL) CD161+ (%)
Control group 6.06 ±1.51 17.02 ±0.67 22.57 ±20.47 16.07 ±4.17 12.05 ±0.88
Experimental group 4.36 ±1.49
∗ 16.31 ±0.45
∗ 12.27 ±14.96 15.53 ±3.63 6.23 ±1.33
∗∗
Mean ± standard deviation, ∗P < 0.05, ∗∗P < 0.01.
increased in the experimental group (Table 4). The mor-
phologic changes in thymus in experimental group include
the following: thickened thymus capsule, decreased lym-
phoid tissue in cortex with adipose tissue replacement, and
increased the size of medulla. The corticomedullary junction
was obscure. Plenty reticular epithelial cells but scarce cor-
puscles are seen.
The sections of spleen in experimental group showed a
decrease in size and number of lymphoid nodules, thinner
lymphatic sheath around arteries with less lymphocytes. In
otherhand,markedincreaseinﬁbrotictissuewithmanyma-
crophages is observed in spleen medulla.
The liver structure and the central vein structure in ex-
perimentalgroupwerechangeddramatically.Thehepatocyte
sinusoids were compressed by the swelling hepatocytes with
balloon degeneration. Eosinophilic changes and eosinophilic
bodies were identiﬁed in hepatocytes.
Ovarian from experimental group showed atrophic
changes with decrease in number of follicles and increase
amount of ﬁbrotic tissue.
4. Discussion
ThePBDE-209isaverypopularbrominatedﬂameretardant.
However, adverse eﬀects of PBDE-209 use on public health,
especially its immunotoxicity, remain obscure due to a pauc-
ity of toxicological and epidemiological data regarding long-
term PBDE-209 exposure. A large body of studies indicate
t h a tP B D E - 2 0 9c a nb es u s t a i n e di ne n v i r o n m e n ta n da c c u -
mulatedinterrestrialbiota,causingliverandthyroiddamage
and retardation of nerve system [12, 13]. Immunotoxicity of
PBDEs has been previously reported in the Great Lakes eco-
system [14, 15]. However, immunotoxicity caused by PBDE-
209 in dams following long-term exposure has not yet been
reported. To our best knowledge, this is the ﬁrst paper
regarding immunotoxicity in dams after long term PBDE-
209 exposure. After long-term exposure to PBDE or DE71, a
mixture of PBDE, no change in body weight gain in perinatal
or adult rat has been reported. In addition, no damage to hu-
man body is found below toxic levels of PBDEs [16–18]. In
present study, dams exposed to PBDE-209 for more than





209, determination of the level of Th1/Th2 polarising cyto-
kines, such as interleukin-4 and interferon-γ,i sv e r yi m p o r -
tant to evaluate the immunotoxicity of PBDE-209 since the
initial encounter with the bacteria, parasites, yeasts, and vir-
uses is crucial for the developing harmful autoimmune res-
ponse postnatal in two aspects [19]. On one hand, a Th1 is
responsible for producing of complement-ﬁxing IgG2a iso-
type antibodies and the activation of natural killer (NK) cells
as well as cytotoxic CD8+ T cells that is releasing interferon-γ
and perforin. On other hand, the Th2 cells produce the cyto-
kineinterleukin-4andcanactivatemastcellsandeosinophils
to eradicate helminths and other extracellular parasites. To-
gether,Th1-andTh2-speciﬁccytokinespromotegrowthand
diﬀerentiationofaspeciﬁcT-cellsubset.Inthepresentstudy,
we observed no signiﬁcant diﬀerences in levels of interferon-
γ and interleukin-4 in rats exposed to PBDE-209, although
Watanabe reported that a signiﬁcant elevation in level of in-
terferon-γ in animal treated with 1000ppm DBDE [20]. The
possible underlying causes for this may be related to the dur-
ationofPBDE-209exposureorthedosingofPBDE-209used
inpresentstudythatwasnotsuﬃcienttoinducetheseeﬀects.
T lymphocytes play a pivotal role in immune defence.
Therefore, T lymphocytes are good candidates for studying
immunotoxicity and risk assessment. T lymphocytes play
roles in cellular immune regulation and immune surveil-
lance. A variety of subsets of T lymphocytes can be identiﬁed
by their cell surface markers, such as CD3 and CD4. B ly-
mphocytes involve humoral immune regulation. The third
typeofimmunecells,theNKcells,participatesincellularim-
mune regulation and immune surveillance. We demonstra-
ted a decreased proportion of CD3+,C D 4 +,C D 3 +CD8+,
CD3+CD4+, CD161+, and CD4+/CD8+ T cells (Figure 1)i n
the thymus of PBDE-209-exposed dams. The percentage of
CD161+ NK cells (Table 3) was also decreased. However,
the proportions of CD8+,C D 4 +CD8+,C D 4 −CD8+ and
CD4+CD8− were changed following PBDE-209 treatment.Mediators of Inﬂammation 7
Table 4: Histological scoring of thymus, spleen, ovaries, and liver injury.
Group Thymus Spleen Ovaries Liver
Control group ND ND ND ND
Experimental group 2.5 ±0.20∗∗ 2.3 ±0.15∗∗ 3.1 ±0.16∗∗ 3.5 ±0.13∗∗
ND: not detectable, mean ± standard deviation, Mean ± standard deviation, ∗P < 0.05, ∗∗P < 0.01.
We measured the proliferation of T and B lymphocytes
(Table 2) from exposed rats by using CCK-8 method. The
CCK-8 method is similar to the MTT method in technique.
Previous experiments have showed that CCK-8 method was
more sensitive than other methods in detecting lymphocyte
proliferation in response to 5μg/mL phytohemagglutinin
or lipopolysaccharide. By CCK-8, the T and B lymphocyte
multiplication was suppressed after PBDE-209 treatment.
Interactions between innate immune system and adaptive
immune reactions are now widely viewed as essential for a
normal immune response [21]. Most pathogens elicit a hu-
moral immune response that is characterised by an early
rise in antigen-speciﬁc IgM followed by aﬃnity maturation,
isotype switching, and the ensuing rise in antigen-speciﬁc
IgG,IgA,andIgEantibodies.Therefore,wemeasuredchange
inlevelofIgMandIgGinPBDE-treatedratsinpresentstudy.
The levels of serum IgG and IgM (Table 3) were signiﬁcantly
decreased. This ﬁnding suggests that the interaction between
innate immune mechanisms and adaptive immune reactions
could be interrupted in PBDE-209-exposed dams.
Perinatal PBDE exposure has been shown histopatholog-
ically to exacerbate pneumonia in the lungs of oﬀspring mice
givenRSVinfection.AsWatanabeetal.reported,histopatho-
logical analysis of lungs of several oﬀspring mice born to
dams exposed to PBDE at 100ppm, typical features of pneu-
monia with RSV infection, including hypertrophy of the
bronchial epithelium and inﬁltration of lymphocytes, were
apparent [20]. In a follow-up study, Leo et al. have reported
that exposure to a commercial penta-PBDE mixture, PBDE-
71, caused obvious histopathological changes in the adrenal
glands, liver, and ileum [22]. In present histopathological
analysis, our ﬁndings indicate that PBDE-209 exposure in-
duced histopathological changes in thymus, spleen, liver and
ovaries due to PBDE-209 exposure (Figures 2(a)–2(p)).
Thickened thymus capsule decreases lymphoid tissue in cor-
tex with adipose tissue replacement and increases the size
of medulla in thymus. The corticomedullary junction was
obscure. Plenty reticular epithelial cells but scarce corpuscles
are seen. The sections of spleen showed a decrease in size
and number of lymphoid nodules, thinner lymphatic sheath
around arteries with less lymphocytes. In other hand, mar-
ked increase in ﬁbrotic tissue with many macrophages is ob-
served in spleen medulla. The liver structure and the central
vein structure were changed dramatically. The hepatocyte
sinusoids were compressed by the swelling hepatocytes with
balloon degeneration. Eosinophilic changes and eosinophilic
bodies were identiﬁed in hepatocytes. Atrophic changes with
decrease in number of follicles and increase amount of
ﬁbrotic tissue in ovarian.
In conclusion, the ﬁndings in present study demon-
strate, for the ﬁrst time, that PBDE-209 exposure induced
immunotoxicity. Exposure to large doses of PBDE-209 not
only inhibits immune function but also alters the structure
of immune organs. Rats exposure to PBDE-209 showed a
suppression of lymphocyte proliferation and antibody pro-
duction. The evidence regarding immunotoxicity induced by
PBDE-209 in animal from present study may be useful for
dealingwiththepotentialriskofPBDE-209exposureinpub-
lic health. These ﬁndings also emphasize the importance of
avoiding immune toxic contaminants in environment, such
as PBDEs, particularly PBDE-209 in pregnant women. As
such, the mechanism of immunotoxicity of PBDE-209 in
present study should be elucidated as soon as possible.
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